Celldex Therapeutics (CLDX) Tops Q4 EPS by 1c

March 3, 2014 8:04 AM

Celldex Therapeutics (NASDAQ: CLDX) reported Q4 EPS of ($0.27), $0.01 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found